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Nicholas T. Thomas 1, Alyaa M. Zagzoog 1, Christopher S. Fry 1,2 and Jean L. Fry 1,2*
1 Department of Athletic Training and Clinical Nutrition, University of Kentucky, Lexington, KY, United States, 2 Center for 
Muscle Biology, College of Health Sciences, University of Kentucky, Lexington, KY, United States
Vitamin D is an essential nutrient for the maintenance of skeletal muscle and bone health. 
The vitamin D receptor (VDR) is present in muscle, as is CYP27B1, the enzyme that 
hydroxylates 25(OH)D to its active form, 1,25(OH)D. Furthermore, mounting evidence 
suggests that vitamin D may play an important role during muscle damage and regeneration. 
Muscle damage is characterized by compromised muscle fiber architecture, disruption 
of contractile protein integrity, and mitochondrial dysfunction. Muscle regeneration is a 
complex process that involves restoration of mitochondrial function and activation of 
satellite cells (SC), the resident skeletal muscle stem cells. VDR expression is strongly 
upregulated following injury, particularly in central nuclei and SCs in animal models of 
muscle injury. Mechanistic studies provide some insight into the possible role of vitamin 
D activity in injured muscle. In vitro and in vivo rodent studies show that vitamin D mitigates 
reactive oxygen species (ROS) production, augments antioxidant capacity, and prevents 
oxidative stress, a common antagonist in muscle damage. Additionally, VDR knockdown 
results in decreased mitochondrial oxidative capacity and ATP production, suggesting 
that vitamin D is crucial for mitochondrial oxidative phosphorylation capacity; an important 
driver of muscle regeneration. Vitamin D regulation of mitochondrial health may also have 
implications for SC activity and self-renewal capacity, which could further affect muscle 
regeneration. However, the optimal timing, form and dose of vitamin D, as well as the 
mechanism by which vitamin D contributes to maintenance and restoration of muscle 
strength following injury, have not been determined. More research is needed to determine 
mechanistic action of 1,25(OH)D on mitochondria and SCs, as well as how this action 
manifests following muscle injury in vivo. Moreover, standardization in vitamin D sufficiency 
cut-points, time-course study of the efficacy of vitamin D administration, and comparison 
of multiple analogs of vitamin D are necessary to elucidate the potential of vitamin D as 
a significant contributor to muscle regeneration following injury. Here we will review the 
contribution of vitamin D to skeletal muscle regeneration following injury.
Keywords: vitamin D receptor, vitamin D, 25(OH)D, calcitriol, skeletal muscle injury, satellite cells, reactive oxygen 
species, skeletal muscle regeneration
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INTRODUCTION
Vitamin D is a fat-soluble vitamin with critical roles for bone 
and skeletal muscle health. Dietary sources of vitamin D include 
fortified foods, such as bread and milk, fatty fish, some 
mushrooms, and dietary supplements. Additionally, upon 
exposure to ultraviolet B rays, human skin can convert 
7-dehydrocholesterol to vitamin D. After ingestion or synthesis, 
vitamin D is activated by two hydroxylation reactions, occurring 
mainly in the liver and kidneys, to form biologically active 
1,25-hydroxyvitamin D [1,25(OH)D]. In the liver, vitamin 
D-25-hydroxylase converts vitamin D to 25(OH)D. The second 
hydroxylation is carried about by CYP27B1-encoded 
1α-hydroxylase (CYP27B1), which yields 1,25(OH)D (Bikle, 
2000). Though most 1α-hydroxylase activity occurs in the 
kidneys, the enzyme is expressed in other cell types including 
macrophages, monocytes, and muscle fibers (Pojednic and 
Ceglia, 2014). Bioactive 1,25(OH)D is a transcription factor 
affecting the expression of hundreds of genes (Bikle, 2000). 
In this capacity, 1,25(OH)D first binds to its nuclear receptor, 
the vitamin D receptor (VDR). This complex binds to a retinoid 
X receptor (RXR) to form a VDR-RXR heterodimer. The 
heterodimer interacts with genomic vitamin D response elements 
(VDREs) to regulate transcription (Bikle, 2000).
Since serum 25(OH)D best reflects vitamin D exposure and 
absorption, and has a relatively long half-life, this metabolite 
is used to evaluate vitamin D status (Holick, 2009). Serum 
25(OH)D  <  30  nmol/L (12  ng/ml) is defined as vitamin D 
deficiency while 25(OH)D concentrations between 30 and 
50  nmol/L (12–20  ng/ml) are categorized as vitamin D 
insufficiency (Ross, 2011). To support bone health, 25(OH)D 
concentrations > 50 nmol/L (20 ng/ml) are considered adequate 
(Houston et  al., 2007). However, evidence indicates that full 
suppression of parathyroid hormone, which is released when 
vitamin D is needed, occurs at a concentration of about 
100  nmol/L (40  ng/ml; Ginde et  al., 2012), suggesting that 
optimal vitamin D status may be  above cut-points established 
to prevent vitamin D deficiency symptoms. These discrepancies 
in estimates of sufficiency are reflected by a lack of consensus 
on vitamin D cut points in skeletal muscle literature (Table 1), 
making comparisons between studies difficult.
Since sunlight exposure often contributes an appreciable amount 
to overall vitamin D supply, those living in latitudes above 43°N 
are more likely to be vitamin D deficient (Ross, 2011). For example, 
participants living in Erie, Pennsylvania were more likely to 
be vitamin D deficient compared with those in Bradenton, Florida 
(Leary et  al., 2017). People with deeper skin tones and higher 
body fat are also more likely to be  deficient (Leary et  al., 2017). 
A classical 1,25(OH)D function is to promote intestinal calcium 
absorption to maintain blood calcium and bone mineralization 
(Ross, 2011). Severe vitamin D deficiency causes rickets in children 
and osteomalacia in adults, which is characterized by a softening 
and weakening of the bones (Nair and Maseeh, 2012). Vitamin 
D insufficiency is associated with inadequate bone health leading 
to loss of bone density, fractures, muscle weakness, osteopenia, 
and osteoporosis (Holick and Gordon, 2011).
Vitamin D status is also associated with muscle strength 
outcomes across a broad range of age groups (Redzic et  al., 
2013). In older adults, plasma 25(OH)D 
concentrations  <  25  nmol/L are associated with significantly 
lower grip strength (Ranathunga et  al., 2019). In a study of 
younger adults, including participants with deficient and optimal 
vitamin D status, higher baseline 25(OH)D concentrations 
predicted the restoration of strength following an intense resistance 
exercise bout (Barker et  al., 2013). Though vitamin D 
supplementation studies have methodological differences in dosing, 
length of intervention, and participant characteristics (including 
baseline vitamin D status), a wealth of data indicates that 
correcting vitamin D status through supplementation improves 
muscle strength. A 2015 meta-analysis including primarily younger 
participants with 25(OH)D concentrations  <  25  nmol/L showed 
vitamin D supplementation ranging from 4,000 to 60,000  IU 
per week significantly improved both upper and lower body 
strength (Tomlinson et al., 2015). An in-depth review of vitamin 
D supplementation and skeletal muscle strength outcomes in 
human participants may be  found elsewhere (Chiang et  al., 
2017). Here we  will review the contribution of vitamin D to 
skeletal muscle regeneration following injury.
SKELETAL MUSCLE DAMAGE AND 
REGENERATION THROUGHOUT THE 
LIFESPAN
Skeletal muscle is a remarkably plastic tissue, capable of robust 
adaptation and regeneration in response to stress and damage 
(Figure  1). Muscle damage can occur as a result of crush 
injury, ischemia-reperfusion injury, and resistance exercise, 
TABLE 1 | 25-hydroxyvitamin D [25(OHD)] cut points vary significantly across skeletal muscle studies.
25(OH)D cut points in human vitamin D/skeletal muscle studies
Deficient Insufficient Sufficient Optimal
National Academies/Institutes of Medicine standards <30 nmol/L 30 to <50 nmol/L ≥50 nmol/L N/A
Ranathunga et al., 2019 <25 nmol/L 25 to <50 nmol/L N/A N/A
Bang et al., 2018 <50 nmol/L 50 to <100 nmol/L ≥100 nmol/L N/A
Dzik et al., 2018 30 to <50 nmol/L N/A ≥50 nmol/L N/A
Jang et al., 2020 <25 nmol/L 25 to <50 nmol/L 50 to <75 nmol/L ≥75 nmol/L
Kitsu et al., 2020 <50 nmol/L 50 to >75 nmol/L >75 nmol/L N/A
Montenegro et al., 2020 N/A N/A 50 to 100 nmol/L >100 nmol/L
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among other stimuli (McGeachie and Grounds, 1987; Roth 
et  al., 1999, 2000; Mackey and Kjaer, 2017; Kuroda et  al., 
2020) and pre-clinical injury models in rodents offer reproducible 
and controlled experimental models (Hardy et  al., 2016). The 
best-studied model of muscle damage in humans is unaccustomed 
resistance exercise, with high load eccentric muscle contractions 
being a significant driver of muscle damage (Roth et al., 1999, 2000;  
Damas et  al., 2016; Mackey and Kjaer, 2017).
Severe muscle damage is characterized by disruption of 
muscle fiber integrity leading to impairments in structure and 
function of damaged muscle (Roth et  al., 1999, 2000; Mackey 
and Kjaer, 2017). Muscle fiber damage is identified by Z-disc 
streaming and a smeared appearance of sarcomeres, indicating 
ultrastructural damage (Lieber and Fridén, 1999; Damas et  al., 
2016). This damage is further defined by severe disruption of 
the arrangement and structure of contractile proteins (Fridén 
et  al., 1983a,b; Brown et  al., 1997; Roth et  al., 1999, 2000; 
Koh and McNally, 2007; Damas et  al., 2016), leaving behind 
necrotic zones where regeneration of the muscle fiber can 
be initiated (Mackey and Kjaer, 2017). Necrotic zones in damaged 
muscle fibers serve as loci for neutrophil and macrophage 
accumulation (Mackey and Kjaer, 2017), a common theme of 
cellular damage (Uderhardt et  al., 2019). In these damaged 
areas, cell proliferation is increased in response to heightened 
apoptosis and muscle fiber biogenesis, and this increased cellular 
turnover aids in the regeneration of viable muscle tissue (Mackey 
and Kjaer, 2017).
Muscle fiber damage is a unique form of cellular stress 
whereby the basement membrane of the damaged fiber is 
preserved, allowing for regeneration and adaptive remodeling 
of the fiber, as opposed to de novo fiber formation (Fridén 
et  al., 1983a,b; Mackey and Kjaer, 2017). This regenerative 
potential of muscle fiber damage is unique, as comparable 
cellular stress in mitosis-competent cell types often necessitates 
de novo cell formation (Liao et  al., 1997; Griffiths et  al., 1999). 
The unique nature of muscle fiber damage and robust regenerative 
potential is owed to its resident stem cell population and 
multinucleation (Lepper et al., 2011). Skeletal muscle stem cells 
are termed satellite cells (SC), due to their residency on the 
periphery of the muscle fiber, between the basal lamina and 
sarcolemma (Katz, 1961; Mauro, 1961). SCs are indispensable 
for regeneration after severe muscle injury (McCarthy et  al., 
2011; Murphy et  al., 2011; Sambasivan et  al., 2011;  
Lepper et  al., 2011), and are characterized by constitutive 
FIGURE 1 | Vitamin D status contributes to muscle damage and regeneration. Vitamin D deficiency leads to mitochondrial dysfunction, decreased adenosine 
triphosphate (ATP) production, increased reactive oxygen species (ROS) production, oxidative damage, muscle atrophy, and impaired muscle function. These 
symptoms of deficiency may exacerbate similar symptoms that typically occur with muscle damage (left panel). During muscle regeneration (right panel), 
hydroxylated, activated vitamin D [1,25(OH)D] stimulates an increase in vitamin D receptor (VDR) abundance in satellite cells and central myonuclei. These changes 
in VDR abundance are accompanied by inhibition of satellite cell proliferation and stimulation of differentiation, which may contribute to maintenance of satellite cell 
self-renewal capacity. Signaling at the VDR also increases mitochondrial biogenesis and fusion signaling, inhibit ROS production, and thereby mitigate antioxidant 
demand, which may contribute to a more competent regenerative phenotype. Created with BioRender.com
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expression of Pax7 (Seale et  al., 2000). SCs are activated after 
damage to the surrounding muscle and undergo asymmetric 
division to generate a “sister” and a “daughter” cell. The sister 
cell is able to return to quiescence, maintaining the resident 
SC pool. The daughter cell differentiates, progresses through 
the myogenic program, and eventually fuses with the surrounding 
muscle tissue and donates its nucleus (Zammit et  al., 2004).
Recent evidence suggests that vitamin D signaling also 
contributes to muscle regeneration. In skeletal muscle of 
mature and aged mice, protein expression of VDR is closely 
associated with serum concentration of 25(OH)D (Srikuea 
et  al., 2020). The VDR and vitamin D-activating enzyme 
CYP27B1 are lowly expressed in homeostatic skeletal muscle 
in vitro and in vivo, evidenced by immunocytochemical and 
immunohistochemical visualization and immunoblotting in 
both C2C12 myoblasts and whole mouse muscle (Srikuea 
et al., 2012, 2020). After muscle injury, the minimal expression 
of VDR and CYP27B1 observed in homeostatic conditions 
is starkly augmented. Vitamin D receptor expression is 
marginally detectable in uninjured skeletal muscle but is highly 
expressed and localized to regenerating muscle fibers after 
muscular injury (Figure  2; Srikuea et  al., 2012), and is 
colocalized with central myonuclei (Srikuea and Hirunsai, 
2016). Furthermore, endogenous VDR is expressed at detectable 
levels in SCs in regenerating skeletal muscle after injury, 
substantiated by colocalization of the Pax7 transcription factor 
and VDR protein (Srikuea and Hirunsai, 2016). The role of 
the vitamin D system in muscle regeneration is further 
supported by rapidly increased Pax7 and VDR protein expression 
in skeletal muscle initiating a repair response after an acute 
bout of damaging high-intensity exercise (Puangthong et  al., 
2020), demonstrating that the myogenic repair system and 
vitamin D system are both rapidly and concurrently initiated 
after damage to skeletal muscle.
Although muscle regeneration is highly efficient, the 
regenerative process can be  compromised in pathological 
conditions (myopathies) and in aged individuals. Compromised 
regenerative processes in skeletal muscle during aging provide 
a particularly interesting area of study, as they are multifactorial 
and complex. Skeletal muscle mass peaks around the third 
decade of life and gradually decreases over time, with observable 
loss starting in the fifth decade (Janssen et  al., 2000). A 
hallmark of age-related muscle atrophy is an imbalance 
between muscle protein synthesis and degradation. During aging, 
FIGURE 2 | Localization of Vitamin D Receptor (VDR) in regenerating mouse and human skeletal muscle. (A,B) Muscle regeneration was induced in the mouse 
tibialis anterior muscle by injecting BaCl2 (1.2%), and the tibialis anterior muscle was harvested 7 days following injury. Immunohistochemical analysis revealed 
regenerating fibers with centrally-located myonuclei (A, DAPI) show strong positive VDR expression (B, red puncta) in myonuclei. (C,D) A vastus lateralis biopsy was 
obtained from a human research participant 7 days after severe thermal injury, which we have shown to induce significant skeletal muscle regeneration (Fry et al. 
2016). Myonuclear localization of VDR (D, red puncta) is observed, with the strongest VDR intensity present within myonuclei (C, DAPI) of small, regenerating fibers. 
In all images, laminin (green) denotes the fiber border. In images A and C, DAPI (blue) denotes nuclei. In images B and D, DAPI is omitted to allow visualization of 
VDR staining within nuclei. Scale bar = 100 μm.
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research has shown increases in protein degradation signaling 
(Cai et al., 2004) and anabolic resistance (Welle et al., 1993), 
which contribute to the observed loss of muscle mass. 
Additionally, impaired mitochondrial function and resultant 
excessive ROS production have been implicated in age-related 
muscle loss (Short et al., 2005). These declines in mitochondrial 
health have been attributed to impaired mitochondrial 
processes such as fusion and fission (Chabi et  al., 2008; 
Gouspillou et al., 2014; Leduc-Gaudet et al., 2015; Liu et al., 
2020), mitophagy (García-Prat et  al., 2016), and biogenesis 
(Chabi et  al., 2008). Further, the loss in skeletal muscle 
mass is coupled with decreases in the resident SC pool 
(Shefer et  al., 2006) and SC activity (Conboy, 2003). 
Age-associated reductions in abundance and functionality 
of SCs induce significant decrements in the muscles’ 
regenerative capacity, which is often associated with 
accumulation of fibrotic material. This increase in fibrosis 
may be  due to SC transition to a fibrogenic phenotype 
(Stearns-Reider et  al., 2017) and resultant decline in 
SC-mediated regulation of fibroblast activity (Fry et al., 2017).
In mice, VDR protein expression is increasingly elevated 
from development through maturation and aging (Srikuea 
et  al., 2020); however, a study in human muscle showed an 
inverse relationship between skeletal muscle VDR expression 
and age (Bischoff-Ferrari et  al., 2004). VDR expression is 
strongly associated with changes in circulating 25(OH)D 
concentrations following vitamin D3 supplementation in older 
women with vitamin D insufficiency (25OHD of 
46.3  ±  9.5  nmol/L; Ceglia et  al., 2013). In mice, elevated 
VDR expression in aged skeletal muscle is also associated 
with central nucleation of muscle fibers (Srikuea et  al., 2020) – 
typically indicative of muscle fibers recovering from a damaging 
stimulus. Further understanding the environment facilitating 
deficits in muscle regeneration, and perhaps the contribution 
of vitamin D signaling, could lead to the development of 
novel therapeutic strategies that support greater myogenic 
potential throughout the lifespan.
VITAMIN D AND MITOCHONDRIAL 
HEALTH
Vitamin D deficiency and insufficiency, when combined typically 
defined as 25(OH)D concentrations < 50 nmol/L, are associated 
with muscle atrophy and deficits in muscle strength in several 
clinical models (Sato et  al., 2005; Tagliafico et  al., 2010; van 
Langenberg et  al., 2014; Almurdhi et  al., 2017; Bang et  al., 
2018). While many studies of vitamin D deficiency and 
insufficiency focus on its impact on protein synthesis and 
degradation, there is also a growing body of evidence to suggest 
that vitamin D supplementation in deficient individuals improves 
measures of mitochondrial density and function (Sinha et  al., 
2013; Rana et al., 2014). These studies are supported by research 
in rodent models, where vitamin D supplementation in deficient 
animals improves the balance between muscle protein synthesis 
and degradation, as well as measures of mitochondrial density 
and function (Gogulothu et  al., 2020).
Due to evidence implicating compromised mitochondrial 
health as a key factor in the pathology of vitamin D deficiency-
induced atrophy, mechanistic action of vitamin D on skeletal 
muscle atrophy – particularly regarding mitochondrial health – 
has gained attention in recent studies. Overexpression of VDR 
in rat skeletal muscle results in increased skeletal muscle 
hypertrophy, driven by increases in anabolic signaling, ribosomal 
biogenesis, and protein synthesis (Bass et  al., 2020). While the 
effect of VDR overexpression on mitochondrial dynamics has 
not been studied, recent studies have confirmed that vitamin 
D regulates oxidative capacity through binding of 1,25(OH) 
D to the VDR in skeletal muscle (Ashcroft et  al., 2020). 
Furthermore, mitochondrial ATP production is significantly 
reduced in VDR-knock down C2C12 myoblasts, supporting 
the idea that the absence of 1,25(OH)D signaling at the VDR 
may significantly reduce ATP availability. This could have 
important consequences for muscle regeneration, which has 
shown to be  hampered by loss of mitochondrial capacity (Jash 
and Adhya, 2012). Interestingly, reductions in ATP generation 
following VDR knock-down occurred independently of changes 
in many measures of mitochondrial machinery, including electron 
transport system (ETS) subunits I-V, citrate synthase, and 
cytochrome c oxidase (Ashcroft et  al., 2020). These results 
were recapitulated by an in vivo experiment in vitamin D 
deficient mice, which showed decrements in maximum oxidative 
capacity in the absence of differences in protein expression of 
ETS complexes I-V (Ashcroft et  al., 2020).
Studies of VDR ablation suggest that 1,25(OH)D regulation 
of oxidative capacity can occur independently of significant 
changes in mitochondrial density and ETS protein abundance. 
This may be  explained in part by a study showing that 
VDR-knockdown in C2C12 myotubes results in an increase 
in optic atrophy 1 (OPA1) abundance, which was proposed 
to be  a compensatory mechanism to rescue deficits in 
mitochondrial function resulting from vitamin D deficiency 
(Ashcroft et  al., 2020). Optic atrophy 1 is a marker of fusion 
of the inner membrane on mitochondria, which results in 
larger mitochondria and increased oxidative capacity (Kushnareva 
et  al., 2013). In contrast, an increase in OPA1 expression was 
observed after vitamin D supplementation in vitamin D deficient 
mice with statin-induced myopathy (Ren et  al., 2020), as well 
as in human skeletal muscle cells treated with 1,25(OH)D 
(Ryan et al., 2016). While these studies all suggest that 1,25(OH)
D treatment or VDR expression alter OPA1, it is unclear why 
both VDR knockdown and 1,25(OH)D treatment led to increased 
OPA1 expression. Additionally, few studies have explored the 
effect of different vitamin D analogs on oxidative capacity, but 
in human skeletal muscle cells, only 1,25(OH) administration 
increased oxygen consumption rate, while exposure to both 
25(OH)D and vitamin D3 significantly reduced it (Ryan et  al., 
2016). Given these disparate findings, future research should 
clarify the impact of VDR expression and different vitamin 
D analogs and doses on mitochondrial dynamics.
In addition to reductions in mitochondrial ATP production, 
another mechanism by which vitamin D deficiency may 
contribute to muscle atrophy is excess mitochondrial ROS 
production (Ricca et  al., 2018). While normal levels of ROS 
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are important for skeletal muscle signaling following injury, 
excessive ROS production that overwhelms protective antioxidant 
systems can be  deleterious to muscle health (Le Moal et  al., 
2017). Vitamin D deficiency has been shown to increase lipid 
(Cielen et  al., 2016; Dzik et  al., 2018) and protein (Bhat and 
Ismail, 2015; Dzik et  al., 2018) oxidation in skeletal muscle. 
Additionally, vitamin D deficiency causes alterations in 
antioxidant enzyme activities (Bhat and Ismail, 2015; Dzik 
et  al., 2018). Interestingly, while vitamin D deficiency was 
associated with increased superoxide dismutase (SOD) activity 
in humans experiencing chronic lower back pain (Dzik et  al., 
2018), a study of rats showed a decrease in SOD activity in 
the plantaris of deficient animals (Bhat and Ismail, 2015). 
However, both studies report that deficiency results in an 
increase in muscle glutathione peroxidase (GPx) activity. The 
difference between these two studies may result from species 
differences (rat vs. human), the presence of muscle pathology, 
or any number of other factors. Notwithstanding, vitamin D 
supplementation was associated with correction of alterations 
in SOD and GPx activities in both studies. There are clear 
opportunities for future studies to elucidate the impact of 
vitamin D status on antioxidant systems in human participants.
In several models, providing vitamin D analogs exerts a 
protective effect on skeletal muscle and cells undergoing oxidative 
stress. Administration of 1,25(OH)D in vitro resulted in a 
reduction in ROS production, lipid and protein oxidation, 
protein ubiquitination, muscle proteolysis, intracellular damage 
and gene markers for atrophy, and an increase in SOD activity 
and markers of mitochondrial biogenesis (Bhat and Ismail, 
2015; Chang, 2019). There is a paucity of data regarding the 
protective effects of vitamin D analogs in vivo. However, one 
study of patients experiencing chronic lower back pain revealed 
that vitamin D3 supplementation resulted in lower Cu/Zn SOD 
and GPx activity in paraspinal muscle compared to deficient 
individuals. These differences in antioxidant activity were 
mirrored by lower protein and lipid peroxidation. On the other 
hand, the same measures in un-supplemented, vitamin D replete 
patients did not differ from deficient patients (Dzik et  al., 
2018). These results not only underscore the importance of 
vitamin D signaling for optimal redox balance, but also highlight 
how the provision of vitamin D analogs promote muscle 
mitochondrial health during oxidative stress (Figure  1).
SATELLITE CELL MITOCHONDRIAL 
FUNCTION AND VITAMIN D
Adequate oxidative capacity is critical for skeletal muscle 
regeneration following injury. In addition to providing energy 
for protein synthesis, mitochondria play an important role in 
regulating SC activity. Quiescent SCs have less mitochondria 
and lower oxidative capacity than activated, differentiating SCs, 
and mitochondrial activity is a key process underlying SC 
activation (Latil et  al., 2012). This lower oxidative capacity 
has been recapitulated in vivo, where reduced mitochondrial 
respiration of SCs was associated with a greater proportion 
of SCs expressing self-renewal markers in endurance-trained 
mice (Abreu and Kowaltowski, 2020). In addition to the 
importance of metabolic reprogramming, other mitochondrial 
processes are implicated in optimal SC function. For instance, 
competent mitophagy has been shown to be  necessary for 
normal SC activity in a study that examined Parkin null mice 
(Esteca et  al., 2020). Parkin is an E3 ubiquitin ligase that is 
essential for regulation of mitophagy. Parkin knockout resulted 
in increased SC proliferation and impaired differentiation in 
mouse skeletal muscle following injury with cardiotoxin. These 
changes in SC activity were accompanied by delayed skeletal 
muscle fiber repair and smaller muscle fibers during regeneration 
(Esteca et  al., 2020).
Another means by which mitochondria influence SC activity 
is through production of ROS, which stimulate symmetric 
division, followed by terminal differentiation (Mohammad et al., 
2019). Interestingly, a study of human skeletal muscle myoblasts 
showed that vitamin D treatment resulted in inhibition of 
myoblast proliferation that was accompanied by an increase 
in differentiation and mitochondrial oxygen consumption rate. 
The authors proposed that decreased proliferation induced by 
vitamin D may serve to maintain SC quiescence and thus 
maintain the stem cell population in muscle. Conversely, the 
increase in mitochondrial oxygen consumption rate likely serves 
to power the increase in synthesis of metabolic machinery 
that accompanies differentiation and mature myotube formation 
(Montenegro et  al., 2019). Taken together, these data suggest 
that vitamin D may modulate SC activity via alterations in 
mitochondrial density or function. Since measures of 
mitochondrial density and ROS production were not assessed, 
it is difficult to speculate on the nature of the changes in 
mitochondria that caused increased oxygen consumption rate, 
and whether alterations in ROS production may have contributed 
to the changes in SC activity. More research is needed to 
determine how vitamin D signaling affects mitochondrial 
function and regulation of SC activity.
Taken together, the global effect of vitamin D on mitochondrial 
function and the presence of VDR in SCs of regenerating 
muscle (Srikuea et  al., 2012) suggest an interplay between 
mitochondria and SCs during muscle repair. Indeed, CYP27B1 
is expressed in mitochondria, suggesting an intrinsic link 
between vitamin D activation and mitochondria (Nakamura 
et al., 1997). However, more research is needed to fully understand 
the effects of vitamin D on the relationship between mitochondria 
and SC activity following skeletal muscle injury. Elucidation 
of the precise nature of signaling between the VDR, SCs, and 
mitochondria may provide avenues for treatment of skeletal 
muscle atrophy where one or more of these components 
in compromised.
VITAMIN D ANALOGS AND SKELETAL 
MUSCLE INJURY
A potential regenerative role of the vitamin D system in injured 
skeletal muscle is supported by improved cellular turnover and 
enhanced muscle function with subcutaneous administration 
of vitamin D3 after crush injury in rats (Stratos et  al., 2013). 
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With vitamin D3 treatment initiated immediately after injury, 
proliferation of cells in the interstitium of injured skeletal 
muscle is elevated with a concurrent decline in necrotic cells 
(Stratos et  al., 2013) – supportive of enhanced activity of 
mononuclear cells with potential roles in muscle repair, such 
as various immune cells, macrophages, and fibrogenic cells. 
Though vitamin D3 administration enhanced activity of 
mononuclear cells within the injured skeletal muscle, Pax7+ 
SC abundance and muscle morphology were not clearly altered 
at any time point through 42  days post-injury. At the same 
time, vitamin D3-exposed rats showed higher peak tetanic 
torque after the severe crush injury when compared with vehicle 
controls (Stratos et al., 2013). Interestingly, the timing, delivery, 
dose, and vitamin D analog may be crucial to optimize muscle 
regeneration after injury. When 1,25(OH)D (the bioactive form 
of vitamin D) is provided in a delayed manner by intramuscular 
injection 4  days after BaCl2 muscle injury, no regenerative 
benefit is observed (Srikuea and Hirunsai, 2016). Both 
physiological and supraphysiological delayed intramuscular 
administration of 1,25(OH)D elevated VDR protein expression 
in injured muscle, but neither delayed dose produced larger 
muscle fibers 8  days after injury. In fact, mice receiving a 
supraphysiological delayed dose of 1,25(OH)D showed impaired 
SC differentiation and subsequent de novo myogenesis and 
presented with injured skeletal muscle having smaller muscle 
fibers and excessive accumulation of fibrotic materials (Srikuea 
and Hirunsai, 2016). In both the aforementioned studies where 
different vitamin D analogs were provided with different timing, 
routes of administration, and doses after muscular injury, muscle 
morphology was not positively altered toward an enhanced 
regenerative phenotype. This is despite improved muscle function 
with immediate systemic delivery of vitamin D analogs after 
injury (Stratos et  al., 2013; Srikuea and Hirunsai, 2016). It’s 
worth noting that rodents consumed standard diets formulated 
to provide sufficient vitamin D. Therefore, it’s possible that 
vitamin D3 or 1,25(OH)D administration would affect deficient 
animals differently. In vivo protocols including both deficient 
and replete animals would help determine the means by which 
treatment with different vitamin D analogs and dosing affect 
muscle recovery and function after injury.
Vitamin D3 supplementation in young males with insufficient 
serum 25(OH)D concentrations resulted in improved knee 
extensor torque output 2 and 7  days after a damaging bout 
of exercise (Owens et  al., 2015) suggestive of enhanced muscle 
regeneration to support superior muscle function. Here, 
insufficiency for recruitment purposes was defined as 25(OH)
D  <  75  nmol/L, above the Institutes of Medicine (IOM) cut 
point of 50 nmol/L. This study included men in both insufficiency 
and sufficiency ranges as defined by the IOM, which is common 
in human studies investigating vitamin D status and muscle 
phenotypes (Table  1). Nonetheless, in skeletal muscle-derived 
myoblasts isolated and cultured from these same young men, 
administration of 1,25(OH)D enhanced differentiation and 
myotube fusion and resulted in larger myotubes after an in 
vitro mechanical wound injury (Owens et  al., 2015). These 
data suggest that supplementing vitamin D3 in young people 
with marginally insufficient vitamin D status may optimize 
regenerative processes in skeletal muscle after muscular injury. 
This is particularly relevant given the high prevalence of vitamin 
D deficiency in athletes (Farrokhyar et  al., 2015) – associated 
with a higher prevalence of muscle strain injuries (Rebolledo 
et  al., 2018) – and the general population across the lifespan 
(Holick, 2017).
DISCUSSION
Within the last decade, it has become clear the vitamin D 
receptor is expressed in skeletal muscle and has integral roles 
in both recovery following injury and maintaining mitochondrial 
function. What remains to be  determined are the precise 
mechanisms by which it exerts these actions and how varying 
forms, doses, and timing of vitamin D analogs affect the 
outcomes. Though mounting evidence indicates that vitamin 
D3 supplementation supports mitochondrial health and oxidative 
capacity while reducing oxidative stress in deficient patients, 
it is unknown what circulating concentration of vitamin D 
promotes “optimal” mitochondrial health, especially in the 
context of injuries causing oxidative damage where it is established 
that some vitamins turn over more quickly (Kesavan et  al., 
2003; Barbosa et al., 2009). Moreover, different studies evaluating 
strength-associated outcomes have had overlapping sufficiency 
and insufficiency definitions and equivocal results, which makes 
interpretation exceedingly difficult. Though different countries 
and professional bodies recommend different cut points, future 
studies require consistent 25(OH)D cut points for analysis of 
the efficacy of specified outcomes and should evaluate the 
effect of dosing and timing. Specifically, it would be  helpful 
to compare directly efficacy of a single megadose and sustained 
daily supplementation after muscle injuries. Though 
supplementation prior to injury may be realistic in some high-
risk settings, it would also be  helpful to establish how soon 
after injury doses should be  administered since prior 
supplementation will not always be  feasible.
Different natural vitamin D analogs and doses have been 
used to elucidate vitamin D’s cellular functions (Table 2). Most 
in vitro studies administer the active vitamin D metabolite 
1,25(OH)D, which is a hormone regulating about 3% of the 
genome. Though valuable mechanistic insight may be  gained 
from this approach, concentrations of this hormone vary 10,000 
fold across studies applying treatments to C2C12 myoblasts 
and human skeletal-derived muscle myoblasts (Ryan et  al., 
2016; Montenegro et  al., 2019). Few in vitro studies include 
treatments with 25(OH)D, but it is the vitamin D metabolite 
that skeletal muscle cells would be exposed to in vivo. Moreover, 
it is established that 1,25(OH)D alters mineral metabolism 
and carries the risk of clinically dangerous hypercalcemia, so 
it is typically prescribed for patients with hyperparathyroidism, 
chemotherapies enhanced by calcitriol, and conditions promoting 
hypocalcemia (Quarles et al., 1988; Muindi et al., 2002; Tartaglia 
et  al., 2005). Animal studies we  reviewed utilized oral and 
injectable forms of vitamin D3, 25(OH)D, 1,25(OH)D; however, 
no study compared more than one analog in the same experiment. 
Inclusion of both 25(OH)D and synthetic vitamin D analogs 
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that do not target vitamin D’s classical mineral-regulating 
pathways (Brown and Slatopolsky, 2008) in future in vitro and 
in vivo studies would add considerably to the literature.
Furthermore, sport and muscle research has suffered from 
limited inclusion of female subjects and animals. The vast 
majority of animal studies we  reviewed included only male 
rodents, and prior evidence indicates that vitamin D metabolism 
is affected by sex (Dam et al., 2009; Heidari and Haji Mirghassemi, 
2012). Though the inclusion of both biological sexes creates 
variability within an experiment, future studies should include 
both sexes or, particularly for in vivo studies, include only 
female animals when funding and power analyses support the 
inclusion of a single-sex.
In summary, in vitro and in vivo models of 1,25(OH) 
exposure, VDR overexpression and knockdown, as well as 
supplementation in deficient rodents and humans, clearly indicate 
a role for vitamin D in the regeneration of muscle and supporting 
mitochondrial health. Deeper mechanistic inquiries are needed 
to illuminate how differing vitamin D analogs, timing, and 
initial vitamin D status affect skeletal muscle regeneration and 
mitochondrial function and how these processes may 
be  inherently linked.
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